Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009:2009:476897.
doi: 10.1155/2009/476897. Epub 2009 Jul 28.

Oral contraceptives after myomectomy: a short term trial

Stefano Luisi  1 , Valentina Ciani, Massimo Gabbanini, Sofia Sollazzi, Michela Torricelli, Francesco Calonaci, Felice Petraglia
Affiliations

Oral contraceptives after myomectomy: a short term trial

Stefano Luisi et al. Int J Endocrinol. 2009.

Abstract

Following myomectomy the rate of fertility is restored and pregnancy may be attempted with a good outcome. In the present study a 3 month treatment with OCs in a group of women after a myomectomy was evaluated. The drug compliance and side effects, the benefits of OC in order to reduce symptoms, to increase post-surgical hemoglobin levels and to avoid an early pregnancy after myomectomy were analyzed. A group of women (n = 55) each with myoma >/=5 cm was recruited: they presented menorrhagia, pelvic pain, dyspareunia and dysmenorrhae. After laparotomic myomectomy the women were divided into 3 groups. Group 1: women (n = 16) treated with pill A (15 mcg of ethynilestradiol + 60 mcg of gestodene); group 2: women (n = 23) treated with pill B (20 mcg of ethynilestradiol + 100 mcg of levonorgestrel); group 3: women (n = 16) treated with a placebo (oral calcium). After three months from myomectomy and treatment patients in each group reported a reduced menorrhagia, dismenorrhea and pelvic pain. Serum haemoglobin levels increased in all women (P < .05). No pregnancy occurred in any group and the compliance was good. A post surgery treatment by using oral contraceptives guarentees pregnancy prevention, associated with reduction of pain, and improvement of haematologic conditions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Serum haemoglobin concentration after treatment in the three groups. Group 1: women treated with 15 mcg of ethynilestradiol + 60 mcg of gestodene; group 2: women treated with 20 mcg of ethynilestradiol + 100 mcg of levonorgestrel; group 3: women treated with a placebo. * = P < .05.
Figure 2
Figure 2
Improvement of symptoms (dysmenorrhoea, pelvic pain, menorrhagia) after myomectomy and OCs use.
See this image and copyright information in PMC

References

    1. Marshall LM, Spiegelman D, Goldman MB, et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertility and Sterility. 1998;70(3):432–439. - PubMed
    1. Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. British Medical Journal. 1986;293(6543):359–362. - PMC - PubMed
    1. Parazzini F, La Vecchia C, Negri E, Cecchetti G, Fedele L. Epidemiologic characteristics of women with uterine fibroids: a case-control study. Obstetrics and Gynecology. 1988;72(6):853–857. - PubMed
    1. Marshall LM, Spiegelman D, Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstetrics and Gynecology. 1997;90(6):967–973. - PubMed
    1. Romieu I, Walker AM, Jick S. Determinants of uterine fibroids. Post Marketing Surveillance. 1991;5(2):119–133.

LinkOut - more resources